Zameer meets Muslim leaders ahead of budget

Mangaluru, Mar 7: Deputy Chief Minister Dr. Ashwatha Narayana said journalists are facing a challenging task of functioning with credibility while also upholding their professional ethics in this age of globalization where monetary aspects have gained great significance.

Inaugurating the 35th state-level Journalists’ Conference at the Kudmul Rangarao Town Hall on Saturday which was hosted by the DK District Working Journalists’ Union the Deputy CM also said that journalists should refrain from giving priority to political news as that does not serve any purpose for the common man.

Dharmadhikari of the Dharmasthala Temple Dr. D Veerendra Heggade was the chief guest at the event. The souvenir brought out to commemorate the occasion was released by Taranga Editor Sandhya Pai. The Deputy CM also inaugurated a cartoon exhibition organized on the occasion.

Bengaluru, Feb 28: Bengaluru Police Commissioner Bhaskar Rao on Friday said that Section 144 will be imposed near Vidhana Soudha for Budget session starting from March 2.

"Section 144 of the CrPC (prohibits assembly of more than 4 people in an area) will be imposed in the area around Vidhana Soudha from March 2 to March 31 ahead of the Budget session,"Bhaskar Rao said.

The police said that they have intelligence inputs of protests near Vidhana Soudha.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.